You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -2,006.3% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -11.8 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 210.1 | 0.0 |
Price / Book value | 3.6 |
Latest | Forecast | |
---|---|---|
Revenue | 50.5% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2018-01-31 | n/a | -6.72 | -2.00p | -4.8 | 0.0 | n/a | n/a | 0.0% |
2019-01-31 | 0.04 | -5.09 | -1.49p | -3.5 | 0.0 | n/a | n/a | 0.0% |
2020-01-31 | 0.46 | -2.87 | -0.87p | -4.3 | 0.0 | n/a | n/a | 0.0% |
2021-01-31 | 0.32 | -4.47 | -0.99p | -18.8 | 0.0 | n/a | n/a | 0.0% |
2022-01-31 | 0.48 | -9,519.00 | -1.65p | -20.3 | 0.0 | n/a | n/a | 0.0% |
E-therapeutics reaches 'key milestone' in Galapagos collaboration Sharecast News | 12 Apr |
---|---|
E-therapeutics finance chief stepping down due to family Sharecast News | 22 Nov |
eTherapeutics CFO to stand down on 31 December Sharecast News | 22 Nov |
Notice of AGM and Posting of Annual Report | 17-May-22 07:00 |
---|---|
Final results for the year ended 31 January 2022 | 04-May-22 07:00 |
Notification of Full Year Results Date | 27-Apr-22 07:00 |
Key Milestone Achieved on Galapagos Collaboration | 12-Apr-22 07:00 |
Immuno-Oncology Research Collaboration with iTeos | 05-Apr-22 07:00 |